New transplant approach shows promise for AML patients in remission

This study looked at how well a stem cell transplant works for 98 adults with acute myeloid leukemia (AML) who were in their first remission. Patients received a standard chemotherapy regimen before getting stem cells from a matched sibling, matched unrelated donor, or a half-matched family donor. The goal was to see how different factors, like donor matching and immune cell traits, affected outcomes such as engraftment, graft-versus-host disease, and survival.